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Current methods to estimate the quantitative cancer risk of complex mixtures of polycyclic
aromatic hydrocarbons (PAH) such as coal tar assume that overall potency can be derived from
knowledge of the concentration of a few carcinogenic components such as benzo[alpyrene
(B[a]P). Genotoxic damage, such as DNA adducts, is thought to be an essential aspect of PAH-
induced tumorigenesis and could be a biomarker for exposure useful for estimating risk.
However, the role of B[a]P and the relationship of adduct formation in tumorigenesis have not
been tested rigorously in models appropriate for human health risk assessment. Therefore, we
directly compared tumor induction and adduct formation by BIa]P and coal tars in several
experimental protocols, including one broadly accepted and used by regulators. We found that
Bla]P content did not account for tumor incidences after exposure to coal tars. DNA adducts
were found in both tumors and tumor-free tissue and tumor outcomes were not predicted by
either quantitation of total DNA adducts or by the DNA adduct formed by BlalP. These data
suggest that risk assessments based on BIa]P content may not predict accurately risk to human
health posed by environmental PAH. - Environ Health Perspect 106(Suppl 6):1325-1330 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/1325-133Ogoldstein/abstract.html
Key words: coal tar, benzolalpyrene, benzpyrenediolepoxide, DNA adducts, infant mouse, A/J
mouse, liver tumors, lung tumors, forestomach tumors, risk assessment
Before the advent of the national natural
gas distribution network, gas for industrial
and residential use was produced locally
from destructive distillation ofcoal and oil.
Manufactured gas plants (MGP), as such
production facilities were known, were
located in over 1500 communities
throughout the United States (1). One of
the by-products ofgas production was coal
tar, a chemically diverse mixture character-
ized by the presence ofpolycyclic aromatic
hydrocarbons (PAH), including known ani-
mal carcinogens and probable human car-
cinogens such as benzo[a]pyrene (B[a]P)
(2). Environmental coal tars may represent
a potential hazard to exposed individuals.
The risk posed to human health by
these tars is determined through the
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process of cancer risk assessment. Risk
assessment consists of hazard identifica-
tion, dose response, and exposure assess-
ment. Hazard identification of coal tars is
supported by studies ofoccupational expo-
sures (3) and laboratory animal studies,
mostly in rodents (2). Unfortunately,
there is uncertainty in assessing dose and
exposure in occupational studies. Further,
there are few laboratory animal studies
that address dose response to individual
PAH using applicable exposure routes
such as ingestion, and even fewer studies
that delineate outcomes after exposure to
complex tar mixtures.
Proposed risk methodologies for complex
environmental mixtures of PAH, such as
coal tar, emphasize the role of B[a]P in
tumorigenesis (4). However, underlying
assumptions in such an approach (e.g.,
independent action, additivity, absence of
modulation by other agents) have not
been rigorously tested. To overcome these
gaps in our understanding and to provide
data for possible use in human cancer risk
assessment, research was conducted to
delineate the role of B[a]P in tumor
induction and plausible biologic mecha-
nisms in coal tar-induced tumorigenesis.
A series of laboratory studies emphasizing
dose response for tumor induction by coal
tars and B[a]P was undertaken.
Much consideration was given to the
overall experimental design (5,6). A modi-
fication of the protocol developed by the
U.S. National Toxicology Program (U.S.
NTP) (7) to identify potential carcinogens
was selected because this protocol has wide
regulatory acceptance. The usual U.S. NTP
protocol emphasizes hazard identification,
and because a major unresolved issue from
the perspective ofrisk assessment was dose
response, a modified design that emphasized
dose response was adopted. Other experi-
mental approaches used sensitive tumor
systems such as liver tumor induction in
B6C3F, mice treated by ip injections at
15 days of age and lung tumor induction
in sensitive strain A/J mice. These assays
provided information on mechanisms of
tumorigenesis to support tumor incidence
findings and evaluate candidate short-term
assays useful for predicting risk of complex
mixtures. One such candidate for a short-
term predictive assay and molecular
biomarker is quantitation oftotal and com-
pound-specific DNA adducts; we therefore
analyzed DNA adduct formation and
related it to tumorigenesis.
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Results of these varied experimental
approaches indicate that tumor induction
by B[a]P and coal tars share some proper-
ties but there are many differences.
Because of these differences, it appears
risk methodologies for evaluating coal tars
and other complex mixtures of PAH
based on tumorigenesis by B[a]P alone
should be reevaluated.
Materials and Methods
Thestudies utilized three exposure protocols:
2-year (chronic) feeding, ip injection, and
short-term (14- and260-day) feeding.
Two-YearFeedingStudies
Methodological details used in the 2-year
feeding study are discussed by Culp (8).
Briefly, groups of48 five-week-old female
B6C3F1 mice were fed one oftwo compos-
ite mixtures ofcoal tars from different indi-
vidual environmental sites. One coal tar
mixture designated MGP-M7 was formed
by combining equal amounts of tars from
seven individual environmental sites. It had
a final B[a]P content, determined by gas
chromatography/mass spectrometry, of
1840 ppm. The coal tar was frozen in liq-
uid nitrogen and blended with powdered
NIH-31 feed to make a 10% master mix
that was subsequently blended with NIH-
31 powdered feed to the desired concentra-
tions. Homogeneity was monitored by
measuring the amount ofB[a]P by ultravio-
let absorbency. Details ofthe diet prepara-
tion are found in Thompson et al. (9).
Mice were given feed with a final coal tar
concentration of0.01, 0.03, 0.3, 0.1, 0.6,
or 1.0% (i.e., 100-10,000 ppm) that con-
tained 0.22 to 22 ppm B[a]P. Other mice
were fed 0.03, 0.1, or 0.3% of a coal tar
mixture designated MGP-M3, a composite
consisting of two of the tars present in
MGP-M7 plus tar from a third tar site not
used in MGP-M7. MGP-M3 contained
2760 ppm B[a]P; B[a]P content in the feed
was 1 to 11 ppm. Other groups of48 mice
received 5, 25, or 100 ppm B[a]P alone in
the diet. The B[a]P was dissolved in ace-
tone, which was subsequently reduced by
evaporation prior to use in animal studies.
Two groups of48 mice served as controls;
one group received feed treated with acetone
(solvent control) and the other group
received untreated food.
The mice were maintained for 2 years.
Mice that died before 2 years and all
animals in groups where overall survival at
2 years was less than 60% were subjected
to full histopathologic examination to
determine tumor incidence and nontumor
pathology. Tumor incidence and pathology
were determined in all control animals.
Tumor and control tissues were fixed in
10% buffered formalin and, after processing,
were paraffin embedded.
Other groups of four male mice each
were fed B[a]P at doses of 2.5 to 50
mg/kg or MGP-M7 at 0.1 to 2% for 3 to
4 weeks. DNA adducts were determined
in lung, liver, and forestomach tissue
using 32P-postlabeling (10).
Studies UsingIntraperitoneal Injection
At 15 days ofage (birth=day 1), groups of
male B6C3F, mice were administered a) a
single ip injection of B[a]P (125, 250, or
375 pg), b) 7980 pg coal tar from a single
site (MGP-4) containing 12.5 pg B[a]P, or
c) 7980, 3990, or 1995 pg MGP-M7 con-
taining 14.7, 7.8, and 3.9 pg B[a]P, respec-
tively. Twenty-six, 39, and 52 weeks
postinjection, groups of30 mice were sac-
rificed and tumor incidences in lung, liver,
and forestomach were recorded. Tumors
were embedded in paraffin using standard
histologic techniques after alcohol-based
fixation (STAT fix, Stat Path, Riderwood,
Massachusetts). Contemporaneous groups
of six similarly exposed mice were har-
vested at times postexposure for DNA
adduct analyses using 32P-postlabeling and
thin layer chromatography (TLC).
In another study, 15-day-old female
B6C3F, mice were administered B[a]P or
MGP-4 by single ip injection and assessed
for tumor formation at 26, 39, and
52 weeks.
In a third set of studies, individual
PAH were combined into a synthetic mix-
ture based on weight percent of 17 marker
PAH contained in MGP-4, including
B[a]P (whose concentration was varied to
deliver a final dose of 26.75 to 126.75
pg/mouse), but omitting indeno[1,2,3-
cd]pyrene, dibenz[a,h]anthracene, and
benzo[g,h,i]perylene, which were not
available in sufficient quantities at the start
of the study (11,12). The reconstituted
mixtures were administered in a single ip
injection to groups of thirty 15-day-old
males at a dose of 193 mg/kg. In a second
approach, the B[a]P content was fixed at
0.09% of the total PAH and the recon-
stituted mixture given as a single ip
injection at 193, 535, and 1041 mg/kg.
Tumorigenesis and 32P-postlabeling DNA
adduct assays were conducted.
The compositions ofMGP-4, MGP-M7,
MGP-M3, and the reconstituted mixture
are shown in Table 1.
Studieswith 14 to 260 Days
ofFeeding
Groups of 21 to 30 female A/J mice 7
weeks of age were fed MGP-M3 (0.1 or
0.25%) or B[a]P (98 or 16 ppm) in a gel
diet (13) for 260 days, and the induction of
forestomach and lung tumors was deter-
mined. Tumor induction was similarly
determined in other groups of 30 females
given a single ip injection of 1790 pg B[a]P
as a positive control. In another study,
female A/J mice were fed coal tar and B[a]P
diets similar to those in the 2-year feeding
Table 1. Composition of an environmental coal tar (MGP-4), two mixtures of environmental coal tars (MGP-M7,
MGP-M3), and a chemically reconstituted mix.a
Aromatic compound MGP-4 MGP-M7 MGP-M3 Reconstituted mix
Indan 0.2 1.4 0.5 0.2
Naphthalene 29.8 27.3 31.6 23.8
2-Methyinaphthalene 21.4 13.9 10.5 23.2
1-Methyinaphthalene 12.3 8.1 5.5 13.3
Acenaphthylene 6.9 3.9 5.6 7.7
Acenaphthene 0.5 2.5 1.2 0.6
Dibenzofuran 0.6 1.8 1.8 0.7
Fluorene 3.9 4.5 4.7 4.3
Phenanthrene 9.7 9.4 9.9 10.5
Anthracene 3.1 3.1 2.8 3.4
Fluoranthene 2.7 6.1 6.2 2.4
Pyrene 3.9 6.3 7.1 4.3
Benz[a]anthracene 1.3 2.9 3.3 1.4
Chrysene 1.3 2.9 2.9 1.5
Benzo[bJfluoranthene 0.8 2.6 2.8 0.8
Benzo[k]fluoranthene 0.3 0.9 1.0 0.9
Benzo[alpyrene 0.9 2.3 2.7 0.9
lndeno[1,2,3-cd]pyrene 2.8 1.6 1.9 0.0
Dibenz[a,h]anthracene 1.0 0.4 0.3 0.0
Benzo[g,h,i]perylene 3.9 1.8 2.1 0.0
&Percent quantified total aromatic compounds.
Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 1326BENZO[alPYRENE AND COAL TAR-INDUCED TUMORIGENESIS
study. After 2 weeks, DNA adduct forma-
tion was evaluated in lung tissue using
32P-postlabeling and separation by high-
performance liquid chromatography
(HPLC) (14).
Results
Two-YearFeedingStudies
In 2-year feeding studies, MGP-M7
resulted in tumors of the small intestine,
forestomach, lung, and liver as well as sarco-
mas, hemangiosarcomas, and histiocytic sar-
comas (Table 2). A similar spectrum of
induced tumors (except small intestine
tumors, which were found at doses higher
than those tested) was found in animals fed
MGP-M3 (Table 1). For MGP-M7 and
MGP-M3, lung tumors (mostly adenomas)
were induced at lower doses than tumors
at other organ sites and thus the lung
represented the most sensitive site for
MGP-induced tumorigenesis. B[a]P
behaved as a point ofcontact carcinogen
and induced tumors of the tongue,
esophagus, and forestomach (Table 2).
Thus, only forestomach tumors were
induced by both coal tars and B[a]P. The
dose response for B[a]P-induced forestom-
ach tumors was similar to that reported by
Neal and Rigdon (15) in CFWmice.
DNA adducts were detected in lung,
liver, and forestomach ofmice fed 2.5 to 50
mg/kg B[a]P for 3 weeks and 0.1 to 2%
MGP-M7 for 4 weeks (Table 3). Adduct
maps (not shown) for mice treated with
MGP-M7 gave a diffuse pattern (diagonal
radioactive zone [DRZ]). The DRZ reflects
adducts formed by many PAH in addition
to B[a]P in MGP-M7 and perhaps adduc-
tion of DNA bases other than guanine.
Adduct patterns with MGP were typical of
patterns observed with complex organic
mixtures. Maps ofDNA adducts from mice
fed B[a]P showed a few discrete spots
includingone cochromatographicwith 1013-
(deoxyguanosin-N2-yl)-7p,8a,9a-trihy-
droxy-7,8,9,1O-tetrahydrobenzo[a]pyrene
(dG-N2-BPDE) formed by reacting B[a]P
diolepoxide with salmon sperm DNA.
Adduct levels in lung, liver, and forestom-
ach in B[a]P-treated mice were similar, sug-
gesting B[a]P reached all three tissues even
though only the forestomach exhibited
B[a]P-induced tumors. Adduct data are
summarized in Table 3.
Studies UsingIntraperitoneal
Injection
When infant male mice were injected ip
with MGP-M7, MGP-4, or B[a]P, liver
tumors (mostly adenomas with some hepa-
tocellular carcinomas) but not forestomach
Table 2. Induced tumorigenesis in mice exposed to coal tar orbenzo[a]pyrene.
Dose,a Dose,a
Experimental model Exposure group mg coal tar pg B[a]P Tumor sites*
Two-yearfeeding in B6C3F1 females MGP-M7 26 47.8 Lung, small intestine
17 31.2 Lung, forestomach, small intestine, hemangiosarcomas
10 18.4 Liver, lung, forestomach, hemangiosarcomas, sarcomas
3.5 6.4 None
1.0 1.8 None
0.35 0.6 None
MGP-M3 9.0 24.8 Liver, lung, forestomach, hemangiosarcomas, histiocytic sarcomas
3.6 9.9 Lung
1.2 3.3 None
B[a]P - 350 Forestomach, esophagus, tongue
- 88 Forestomach
- 17.5 None
Single ip injection, B6C3F1 infant males MGP-4 7.980 12.5 Liver, 43b
MGP-M7 7.980 14.7 Liver, 59b
3.990 7.4 Liver, 25b
1.995 3.7 Liver, 12b
B[a]P - 375 Liver, 79b
- 250 Liver, 52b
- 125 Liver, 45b
Single ip injection, B6C3F1 infant females MGP-4 7.980 12.5 Noneb
B[a]P - 375 Noneb
- 250 Noneb
- 125 Noneb
Single ip injection, B6C3F1 infant males Reconstituted mix 535c 4.8 Noneb
1071C 9.7 Noneb
193c 126.74 Noneb
193c 101.74 Noneb
193c 76.74 Noneb
193c 51.74 Noneb
193c 26.74 Noneb
193c 1.71 Noneb
260-day-feeding, A/J females MGP-M3 5.9 16.3 Lung: 100, 12.7d
2.5 6.9 Lung: 70, 1.19d
B[alP - 257 Lung: 52, 0.59 ; forestomach: 100, 4.22d
- 40.6 Lung: 36, 0.48d; forestomach: 100, 4.22d
Single ip injection, A/J females B[a]P _ 1800 Lung: 100, 15.8dforestomach: 83, 1.83d
*p<0.05 vs control. &Perday per animal. bPercent mice with tumors, 52 weeks postexposure. cDefined PAH, see text. dPercent mice with tumors, tumors per mouse, 260days
postexposure.
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Table 3. DNA adducts in liver, forestomach and lung of B6C3F, mice given benzo[alpyrene or manufactured gas
plants residue.
Total dose
B[a]P, pg MGP, mg
375
12.5
14.7
7.9
3.8
Oral 0
336
819
1638
3255
6510
Oral 0
392
840
1400
2156
3528
0
7.980
7.980
3.990
1.995
0
0
0
0
0
0
0
165.2
344.4
582.4
896.0
1470.0
or lung tumors were induced (Table 2).
Even though MGP-4 and MGP-M7 con-
tained much less B[a]P (12.5 and 14.7 pg)
than the lowest dose ofB[a]P administered
alone (125 pg), overall tumor incidences
were comparable. MGP-M7-induced
tumors tended to arise earlier and MGP-4-
and MGP-M7-induced tumors were
pathologically more advanced than B[a]P-
induced tumors (16). Because tumors of
lung and forestomach were found in
female mice fed B[a]P or MGP-M7 for 2
years but not in infant male mice given sin-
gle ip injections, the ip injection protocol
was repeated using females. No tumors
were induced in lungs, forestomach, or,
most notably, livers of females treated in
this manner (Table 2).
DNA adduct maps similar to those
after feeding MGP-M7 or B[a]P to adult
female mice were found in liver, lung, and
forestomach of ip-injected infant mice
given B[a]P, MGP-4, or MGP-M7 (Table
3). Thus, DNA adducts were found in
liver, lung, and forestomach even though
only liver tumors were induced.
To determine the role of B[a]P in
tumor induction by MGP residues and
whether B[a]P potency was modulated by
noncarcinogenic components, male infant
mice were administered ip injections of
synthetic reconstituted mixtures of PAH
formulated to resemble MGP-4 and con-
taining a range of B[a]P concentrations.
The reconstituted mixtures, including one
with 125 pg B[a]P, a dose of B[a]P that
itself caused liver tumors by 52 weeks
(16), did not induce liver, lung, or
forestomach tumors. In contemporary
DNA adducts, fmol/mg DNA
Liver Forestomach Lung
1023
1290
417
297
210
4
33
90
201
286
905
65
362
714
1907
2454
3121
840
820
138
312
87
11
90
137
199
360
446
112
234
407
812
1489
1792
1851
2664
2319
1290
831
4
43
47
80
126
161
22
422
1259
3021
5367
6776
studies B[a]P administered alone at 250
pg/mouse induced liver tumors but lower
doses of B[a]P (31 and 62.5 pg) did not,
indicating that the B[a]P was active but
that tumor induction was dose dependent.
The reconstituted mixture resembling
MGP-4 was not tumorigenic even up to a
dose of 1071 mg/kg, a much higher dose
than with MGP-4 itself. These results are
summarized in Table 2.
Studieswith 14 to260 Days
ofFeding
A high incidence oflung tumors at a high
multiplicity was found in male strain A/J
mice after ingesting MGP-M for 260
days; nonsignificant incidences and multi-
plicities were found with B[a]P (Table 2).
Ingested B[a]P was an effective tumorigen
in the forestomach, whereas MGP-M3
was not. B[a]P induced lung tumors when
administered as a single ip injection.
Thus, in A/J mice, lung tumor induction
following MGP-M3 ingestion and
forestomach tumor induction following
B[a]P ingestion were similar to results
found in the modified NTP bioassay (8).
The spot cochromatographing with
dG-N2-BPDE in A/J mice fed MGP-M3
for 14 days was investigated further using
HPLC (14). Adducted lung DNA gave
three peaks (Figure 1), two of which
cochromatographed with adducts formed
when lung DNA was isolated from mice
treated with B[a]P or benzo[b]fluoran-
thene and verified for the complex mix-
tures by the method ofWeyand and Wu
(17). The identity of the third adduct
peak is unknown.
Discussion
Even the best available data froinaanfLil
studies of tumorigenesis by PAH are hrot
particularly appropriate for applicatiotero
human health risk assessment (4). Because
B[a]P has been proposed as a basis for
quantitative risk assessment of complex
mixtures ofPAH (4), these studies directly
compared the outcomes from B[a]P alone
to those from coal tars that contain B[a]P.
The data indicate significant d-ifferences
for tumor induction by B[a]P compared to
coal tars:
* Both B[a]P and coal tar induced
forestomach tumors in the 2-year feed-
ing study. B[a]P, but not coal tar,
induced tumors at two sites-tongue
and esophagus. Coal tar, but not B[a]P,
induced tumors in lung, small intestine,
and liver, as well as sarcomas, heman-
giosarcomas, and histiocytic sarcomas
in several sites.
* Doses of 125, 250, or 375 pg B[a]P
alone or coal tar containing 3.8 to 14.7
pg B[a]P induced liver tumors in infant
male mice. Lower doses ofB[a]P (31.5
or 62.5 pg) administered alone did not
induce liver tumors.
* Neither B[a]P nor MGP-M7 caused
tumors in 15-day-old female B6C3F,
mice by single ip injection even though
both induced tumors in 15-day-old
male mice.
* Tumorigenicity in 15-day-old male
mice by coal tar (MGP-4) could not
be recapitulated by a reconstituted
mixture based on component concen-
trations. No tumors were found when
125 pg B[a]P was administered as part
80 - c
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Figure 1. HPLC profile of 32P-postlabeled DNA adducts
isolated from the lungs of female A/J mice after
ingesting 0.25% MGP-M3 in their diets for 14 days.
32P-labeled adducts were subjected to five-dimensional
poly(ethylenimine) cellulose TLC prior to HPLC analysis.
(A) 33.4 min benzo[b]fluoranthene; (B) 45.0 min B[alP;
and (C) 46.3 min unknown.
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of the reconstituted mixture, even
though B[a]P administered alone at
125 pg/mouse induces liver tumors.
Ingested coal tar, but not ingested
B[a]P, induced lung tumors at high inci-
dence and high multiplicity inA/J mice.
Data from the 2-year feeding study are
likely to be given more weight than the
data from the other protocols in human
health risk assessments. Because lung
tumors were induced at lower doses than
tumors at other sites, lung tumor incidence
is likely to form the basis ofany quantita-
tive risk methodology for coal tar. The
choice of lung tumor incidence for risk
assessment is consistent with data in
humans showing incidence oflung cancer
in workers engaged in certain occupations
where exposure to PAH was likely to be
high (3). Using lung tumorigenesis to
assess MGP-PAH risk is supported by
studies that attribute a large portion of
smoking-related cancers to PAH in ciga-
rette smoke, as well as data indicating lung
tissue in rodents is particularly susceptible
to genotoxic effects by complex mixtures of
PAH (17,18).
Lung tumorigenesis was induced at
high frequencies in A/J mice fed MGP-
M3 but not B[a]P. Robinson et al. (19)
detected increased lung tumors in strain A
mice orally gavaged with high doses of
either B[a]P or a coal tar paint prepara-
tion. They concluded that B[a]P could
not account for the level of tumor forma-
tion by the coal tar paint. Increased lung
tumor incidence has been reported in
studies where B[a]P or other PAH are
introduced into the lung by surgical
implantation (20), but the relevance of
data derived using this exposure route is
questionable. Overall, the data suggest
that B[a]P is at best a weak lung carcino-
gen when ingested, and therefore B[a]P
may not be a particularly good surrogate
for use in human health risk assessments
ofcoal tars.
Formation of DNA adducts and
subsequent mutations leading to malig-
nant conversion of cells is a central tenet
of carcinogenic mechanisms proposed for
B[a]P and other PAH. Our data indicate
DNA adduct formation is not sufficient
for tumorigenesis. Ingested B[a]P forms
adducts but does not induce tumors in
lung (Tables 2 and 3). It is possible that
adducts in B[a]P-treated mice were in cells
other than bronchial epithelium (most
MGP-induced tumors were bronchioalveo-
lar adenomas) or occurred primarily in
nondividing cells. In ip-injected male mice
15 days ofage, DNA adducts were found
in liver, lung, and forestomach (Table 3),
but only the liver subsequently had tumors
(Table 2). The role of DNA adducts in
predicting tumorigenesis is uncertain.
One proposed method for establishing
quantitative risk estimates for PAH mix-
tures is based on their relative potencies or
toxic equivalency factors (TEF) (21). In a
TEF approach for PAH, overall potency of
the mixture is expressed relative to B[a]P
and contributions of individual carcino-
genic PAH are taken to be additive (4).
B[a]P is relatively more abundant than
other carcinogenic PAH in coal tar (3) and
it is more potent than other listed carcino-
genic PAH except dibenz[a,h]anthracene.
B[a]P would account for about two-thirds
ofthe overall toxicity ofcoal tars when cal-
culating the toxicity equivalency quotient,
the sum ofTEFs. Using TEFs is question-
able, as the data show no evidence for lung
tumor induction by B[a]P in any of the
assays except by ip injection in sensitive
strain A/J mice.
In an alternative approach, coal tar itself
rather than carcinogenic PAH is considered
the unit ofdose in risk assessments for tars
and contaminated media. This approach is
based on lung tumor incidence and assumes
only minor differences in chemical compo-
sition ofcoal tars, coal tar-contaminated
soil, and coal tar-contaminated water.
However, low-molecular-weight PAH are
lost by volatization or biologically
degraded, whereas high-molecular-weight
PAH are not volatile and biodegrade only
slowly. Aged soil will have relatively more
high-molecular-weight PAH and less low-
molecular-weight PAH than tars. PAH
have a wide range of aqueous solubility;
thus, PAH-contaminated water will have
relatively more water soluble, low-molecu-
lar-weight (3-and 4-ring) PAH and less
insoluble, high-molecular-weight (4-, 5-,
and 6-ring) PAH than tars. Because of
these differences in composition, the risk
approach based on chemical composition
ofcoal tars may not hold for media conta-
minated by tars. In some cases overestima-
tion might result (contaminated water) and
in some cases underestimation might result
(contaminated soil).
Until an accurate predictor of tumori-
genicity is developed, risk assessment
approaches based on exposures to known
carcinogenic PAH may still be a useful
approach. Carcinogenic PAH comprise
about 20% ofthe PAH content ofcoal tars
and up to 70% of the total PAH in aged
soils contaminated by coal tars (22).
Because we have no evidence that B[a]P
deserves a special role or that mixture
potency is the sum ofpotencies normalized
to B[a]P, a risk assessment approach based
on total carcinogenic PAH rather than
weighted TEF likely captures many of the
attributes of the actual carcinogenic mix-
ture (i.e., coal tar) without assuming a piv-
otal role for B[a]P or any other currently
identified carcinogen.
In summary, both tumor induction and
DNA adduct data from three independent
experimental protocols lead us to question
the use ofTEF in cancer risk assessments
for coal tar or other mixtures of PAH.
Until mechanisms of carcinogenicity by
PAH are better understood, an approach
based on naturally occurring carcinogenic
PAH may be useful.
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